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ABSTRACT
Objective: To determine the frequency and clinical manifestations of patients with post-poliomyelitis syndrome (PPS) in a Brazilian division 
of neuromuscular disorders. Methods: A total of 167 patients with prior history of paralytic poliomyelitis was investigated for PPS, based 
on international diagnostic criteria. Other variables analyzed were: gender, race, age at poliomyelitis infection, age at PPS onset, and PPS 
symptoms. Results: One hundred and twenty-nine patients presented PPS, corresponding to 77.2% of the studied population. 62.8% were 
women and 37.2% were men. Mean age of patients with PPS at onset of PPS symptoms was 39.9±9.69 years. Their main clinical manifesta-
tions were: new weakness in the previously affected limbs (69%) and in the apparently not affected limbs (31%); joint pain (79.8%); fatigue 
(77.5%); muscle pain (76%); and cold intolerance (69.8%). Conclusions: Most patients of our sample presented PPS. In Brazil, PPS frequency 
and clinical features are quite similar to those of other countries.
Key words: post-polio syndrome, poliomyelitis, prevalence.
RESUMO
Objetivo: Determinar a frequência e as manifestações clínicas de pacientes com síndrome pós-poliomielite (SPP) em um setor terciário de 
doenças neuromusculares brasileiro. Métodos: Um total de 167 pacientes com história prévia de poliomielite paralítica foi estudado para 
diagnóstico de SPP, de acordo com critérios diagnósticos internacionais. Além da SPP, as variáveis analisadas foram: gênero, raça, idade à 
época da poliomielite aguda e idade no início dos sintomas da SPP. Resultados: Cento e vinte e nove pacientes apresentaram SPP, corres-
pondendo a 77,2% da população estudada. Mulheres constituíram 62,8% dos pacientes e os homens, 37,2%. A média de idade dos pacien-
tes com SPP à época do início dos sintomas foi de 39,9±9,69 anos. Suas principais manifestações clínicas foram: manifestações novas de 
fraqueza em membros previamente afetados (69%) e em membros aparentemente não afetados (31%); dores articulares (79,8%); fadiga 
(77,5%); dor muscular (76%) e intolerância ao frio (69,8%). Conclusões: A maioria dos pacientes da presente casuística apresentou SPP. No 
Brasil, a frequência e as características clínicas da SPP são similares às observadas em outros países.
Palavras-Chave: síndrome pós-poliomielite, poliomielite, prevalência.
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Paralytic poliomyelitis is an old disease that occurred 
sporadically from 1600 to 1300 BC1. However, epidemic po-
liomyelitis is a modern disease related to improvement of 
sanitary conditions of the Western world2. The first epide-
miological data on poliomyelitis in Brazil were known in 
19103. In 1994, the World Health Organization (WHO) de-
clared Brazil as polio-free4.
Some patients have shown a new set of symptoms de-
cades after recovery from acute poliomyelitis, which has been 
called post-poliomyelitis syndrome (PPS). This is a neurologi-
cal disorder characterized by a cluster of symptoms, such 
as new weakness, abnormal muscle fatigability, and mus-
cle and joint pain. Less commonly, muscle atrophy, breath-
ing and swallowing difficulties, and cold intolerance may be 
present5. For a long time, the PPS was not considered a dis-
ease, and since October 2008 the WHO, in its International 
Classification of Diseases (ICD), recognized it as a distinct 
and incurable disease (ICD=G14).
In Brazil, few epidemiological studies on the frequency 
and on the symptoms of PPS were performed. In this scenar-
io, our objective was to determine the frequency and the clin-
ical manifestations of a large series of patients with PPS in a 
Brazilian division of neuromuscular disorders.
METHODS
This study included 167 consecutive patients with prior 
history of poliomyelitis, who were admitted between March 
2003 and June 2004 in the post-poliomyelitis outpatient 
sector of the Division of Neuromuscular Diseases from the 
Department of Neurology and Neurosurgery of the Federal 
University of São Paulo (Unifesp). All patients had paralytic 
poliomyelitis, were born and lived in Brazil. All of them were 
over 18 years of age.
PPS diagnosis was performed according to Halstead’s cri-
teria6. Furthermore, in our sample, we included only patients 
who had functional and neurological stability for at least 15 
years, and the new symptoms should have persisted for more 
than one year7.
Exclusion factors included: patients with paralysis who 
had no clear history of acute infection by the poliovirus; elec-
troneuromyography without typical features of prior infec-
tion by the poliovirus; and patients with other motor neuron 
diseases, such as amyotrophic lateral sclerosis or progressive 
spinal muscular atrophy.
Electroneuromyography was performed in all patients, and 
identified typical features of prior infection by the poliovirus.
The evaluation protocol consisted of a questionnaire 
containing the following variables: age, gender, race, age at 
acute infection by poliovirus, age at onset of PPS symptoms, 
PPS symptoms (new weakness, muscle pain, joint pain, fa-
tigue, cold intolerance, cramps, new atrophy, fasciculation, 
headache, dyspnea, and dysphagia). A neurological exami-
nation was performed by neurologists experienced in neuro-
muscular diseases. Fatigue was considered in those who met 
the score in the Fatigue Severity Scale (FSS).
RESULTS
From the 167 patients included in the study, 129 (77.2%) 
were classified as bearing PPS, of which 81 (62.8%) were wom-
en and 48 (37.2%) were men. Mean age of post-polio patients 
at the time of data collection was 47.3±10.07 years. Their 
average age at acute poliomyelitis infection was 1.11±2.57 
years, and at PPS onset was 39.9±9.69 years. Their average 
time between polio and onset of post-polio symptoms was 
37.0±10.75 years. Ninety percent of patients with PPS had not 
been previously vaccinated (Table 1).
The main clinical manifestations of PPS patients were: 
new weakness (n=129, 100%); joint pain (n=103, 79.8%); fa-
tigue (n=100, 77.5%); muscle pain (n=98, 76.0%); cold intol-
erance (n=90, 69.8%); cramps (n=86, 66.7%); fasciculations 
(n=68, 52.7%); new atrophy (n=63, 48.8%); headache (n=62, 
48.1%); dyspnea (n=53, 41.1%); and dysphagia (n=27, 20.9%), 
as seen in Table 2.
New muscle weakness occurred in the limb with motor 
sequelae in 69% of patients, while 31% of them developed 
weakness in unaffected limbs.
Table 1. Epidemiological characteristics of post-polio syndrome.
Demographics n (%)




Preceding vaccine 11 (9.1)
Mean age acute polioa 1.11 (±2.57)*
Mean age at PPS onset 39.9 (±9.69)*
Mean age at evaluationa 47.3 (±10.07)*
aexpressed in years; n: number of patients; PPS: post-poliomyelitis syndrome; 
*mean ± standard deviation
Table 2. Clinical complaints of patients with post-polio syndrome.
Complaint n %
New weakness 129 100
Joint pain 103 79.8
Fatigue 100 77.5
Muscle pain 98 76.0
Cold intolerance 90 69.8
Cramps 86 66.7
New atrophy 63 48.8
Headache 62 48.1
Respiratory complaints 53 41.1
Dysphagia 27 20.9
n: number of patients.
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DISCUSSION
In Brazil, there are few studies on epidemiological features of 
PPS. It was first reported by Oliveira and Maynard, who saw PPS 
symptoms in 68% of patients with prior history of poliomyelitis8. 
Moreover, Conde et al. evaluated medical records of 132 Brazilian 
patients with PPS and described predictor factors of its severity9.
PPS prevalence depends on the clinical diagnostic cri-
teria applied and on population studied, ranging from 20 to 
80%7,10. In our sample, we found a PPS frequency of 77.2%, 
which is consistent with studies conducted in other coun-
tries. A weakness of our study might be the fact that most 
patients lived in the state of São Paulo, and the data may not 
properly represent the entire Brazilian population.
While many patients in our study had recent complaints 
of decline in muscle strength, the detailed clinical interview 
revealed that it occurred after a prolonged period of clinical 
stability, ranging from 15 to 69 years (average time between 
the polio and onset of post-polio symptoms was 37±10.75 
years). In literature, Halstead and Rossi11 found an average 
time of functional stability of 25 years and an average time 
between the polio and the onset of PPS of 33 years. Dalakas 
et al.12 found a plateau of stability ranging from 15 to 54 years 
(clinical stability interval=28.8 years).
Regarding PPS symptoms, the most frequent in our sam-
ple were new weakness (100%) followed by joint pain (79.8%), 
fatigue (77.5%), and muscle pain (76%), which are also the 
most common symptoms reported in different studies7,9,11-14.
In conclusion, our series of post-polio patients report fre-
quency and clinical manifestations similar to other series of 
non-Brazilian populations and contribute to better under-
standing regional characteristics of the illness.
1. Shepherd G, Simsolo V, Verones IR. Enteroviroses: I – Poliomielite. In: 
Veronesi R, et al. (eds). Doenças Infecciosas e Parasitárias. Rio de 
Janeiro: Guanabara Koogan; 1976, p. 104-124.
2. Nathanson N, Martin Jr. The epidemiology of poliomyelitis: enigmas 
surrounding its appearance, epidemicity and disappearance. Am J 
Epidemiol 1979;110:672-692.
3. Campos VLA, Nacimento RD, Maranhão E. The history of polio in Brazil 
and its control through immunization. Hist Cienc Saúde-Manguinhos 
2003;10(Suppl 2):S1-S24.
4. Raymond M (clinical presentation with discussion by CHARCOT JM). 
Paralysie essentiele de la enfance. Atrophic musculaire consecutive. 
Gax Med (Paris) 1875;4:225-226.
5. Trojan DA, Cashman NR. Pathophysiology and diagnosis of post-polio 
syndrome. NeuroRehabilitation 1997;8:83-92.
6. Halstead LS. Post-polio syndrome: definition of an elusive concept. 
In: Munsat TL (ed). Post-polio syndrome. Boston, MA: Butterworth-
Heinemann; 1991, p. 23-28.
7. Rowland LP, Bach JR, Borg K, et al. March of Dimes International 
Conference on Post Polio-Syndrome identifying best practices in 
diagnosis & cure. White Plains, NY: March of Dime; 2001, 24 p.
8. Oliveira ABS, Maynard FM. Síndrome pós-poliomielite: aspectos 
neurológicos. Rev Neurocienc 2002;10:31-34.
9. Conde MTRP, Oliveira AS, Quadros AAJ, et al. Post-polio syndrome: 
epidemiologic and prognostic aspects in Brazil. Acta Neurol Scand 
2009;120:191-197.
10. Howard RS. Poliomyelitis and the postpolio syndrome. BMJ 
2005;330:1314-1318.
11. Halstead LS, Rossi CD. Post-polio syndrome: clinical experience 
with 132 consecutive outpatients. In: Halstead LS, Weichers 
DO (eds). Research and Clinical Aspects of the Late Effects of 
Poliomyelitis. . White Plains, NY: March of Dimes Birth Defects 
Foundation; 1987, p. 13-26.
12. Dalakas MC, Elder G, Hallett M, Ravits J, Baker M. A long term 
follow-up study of patients with post-poliomyelitis neuromuscular 
symptoms. N Engl J Med 1986;314:959-963.
13. Cosgrove JL, Alexander MA, Kitts EL, et al. Late effects of poliomyelitis. 
Arch Phys Med Rehab 1987;68:4-7.
14. Agre JC, Rodriguez AA, Sperling KB, Symptoms and clinical 
impressions of patients seen in a post-polio clinic. Arch Phys Med 
Rehab 1989;70:367-370.
References
